HK83293A - Composition of pregnanolole comprising a stable oil-in-water emulsion - Google Patents

Composition of pregnanolole comprising a stable oil-in-water emulsion

Info

Publication number
HK83293A
HK83293A HK832/93A HK83293A HK83293A HK 83293 A HK83293 A HK 83293A HK 832/93 A HK832/93 A HK 832/93A HK 83293 A HK83293 A HK 83293A HK 83293 A HK83293 A HK 83293A
Authority
HK
Hong Kong
Prior art keywords
composition
water emulsion
pregnanolole
stable oil
pregnanolone
Prior art date
Application number
HK832/93A
Other languages
English (en)
Inventor
Roland Ingolf Jeppsson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of HK83293A publication Critical patent/HK83293A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK832/93A 1986-02-13 1993-08-12 Composition of pregnanolole comprising a stable oil-in-water emulsion HK83293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition

Publications (1)

Publication Number Publication Date
HK83293A true HK83293A (en) 1993-08-20

Family

ID=20363448

Family Applications (1)

Application Number Title Priority Date Filing Date
HK832/93A HK83293A (en) 1986-02-13 1993-08-12 Composition of pregnanolole comprising a stable oil-in-water emulsion

Country Status (14)

Country Link
US (1) US5028600A (xx)
EP (1) EP0233849B1 (xx)
JP (1) JPH0788305B2 (xx)
AT (1) ATE64526T1 (xx)
CA (1) CA1301651C (xx)
DE (1) DE3770830D1 (xx)
DK (1) DK175504B1 (xx)
ES (1) ES2037742T3 (xx)
FI (1) FI88676C (xx)
GR (1) GR3002299T3 (xx)
HK (1) HK83293A (xx)
NO (1) NO175040B (xx)
SE (1) SE8600632D0 (xx)
SG (1) SG102892G (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
US20020155161A1 (en) * 2000-12-29 2002-10-24 Deckelbaum Richard J. Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compounds
EP3513813A1 (en) * 2002-07-02 2019-07-24 Astrazeneca Ciclesonide-containing sterile aqueous suspension
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EA200700440A1 (ru) * 2004-09-13 2008-02-28 Бхарат Сирумс Энд Вэксинс Лтд. Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность
WO2012096697A1 (en) * 2011-01-14 2012-07-19 Simpkins Cuthbert O Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
WO2013043985A1 (en) * 2011-09-23 2013-03-28 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
SG10201606063RA (en) 2012-01-23 2016-09-29 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
WO2014028398A2 (en) 2012-08-13 2014-02-20 The Regents Of The University Of California Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
IL304912A (en) 2012-08-21 2023-10-01 Sage Therapeutics Inc Treatment methods for epilepsy and status epilepticus
EP2925327B1 (en) 2012-11-30 2024-01-10 The Regents of The University of California Allopregnanolone for treating, reducing or mitigating symptoms of post-partum depression
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
WO2017156103A1 (en) 2016-03-08 2017-09-14 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JP2022514991A (ja) * 2018-12-10 2022-02-16 ハロー・サイエンス・エル・エル・シー 安定な麻酔薬製剤および関連する剤形
CA3151334C (en) * 2019-08-19 2024-04-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Topical neurosteroid formulations
CN114344309B (zh) * 2021-12-30 2024-02-06 南京迈诺威医药科技有限公司 一种别孕烷醇酮衍生物自乳化制剂及其制备方法
US11969434B1 (en) 2022-08-29 2024-04-30 Lipocine Inc. Oral allopregnanolone compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1215702B (de) * 1962-07-03 1966-05-05 Merck Ag E Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen
CA895860A (en) * 1969-11-05 1972-03-21 Kruger Gunther PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液

Also Published As

Publication number Publication date
NO175040C (xx) 1994-08-24
GR3002299T3 (en) 1992-12-30
ATE64526T1 (de) 1991-07-15
US5028600A (en) 1991-07-02
FI88676B (fi) 1993-03-15
FI88676C (fi) 1993-06-28
DK62187A (da) 1987-08-14
DE3770830D1 (de) 1991-07-25
JPH0788305B2 (ja) 1995-09-27
CA1301651C (en) 1992-05-26
FI870589A0 (fi) 1987-02-12
NO175040B (no) 1994-05-16
EP0233849B1 (en) 1991-06-19
EP0233849A1 (en) 1987-08-26
ES2037742T3 (es) 1993-07-01
DK175504B1 (da) 2004-11-15
NO870560D0 (no) 1987-02-12
FI870589A (fi) 1987-08-14
NO870560L (no) 1987-08-14
SE8600632D0 (sv) 1986-02-13
DK62187D0 (da) 1987-02-06
SG102892G (en) 1992-12-04
JPS62192322A (ja) 1987-08-22

Similar Documents

Publication Publication Date Title
HK83293A (en) Composition of pregnanolole comprising a stable oil-in-water emulsion
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
ES8505646A1 (es) Procedimiento para la preparacion de un derivado de insulina
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
IL75637A0 (en) Thymopentin analogs and pharmaceutical compositions containing them
MY101784A (en) Novel pharmacological compounds
IL74066A0 (en) 6,6-ethylene-15,16-methylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactones,processes for the production thereof,and pharmaceutical preparations containing them
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
FR2688499B1 (fr) Procede de preparation de la beta-phenylisoserine et de ses analogues.
DE69018730D1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES471507A1 (es) Procedimiento para la obtencion de piperidino-propanoles
ES8704488A1 (es) Procedimiento para preparar derivados de 3,4-diazol
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
ES8303324A1 (es) "procedimiento para preparar una sustancia activa adecuada para la estabilizacion de prostaglandinas y sus derivados".
ES2019156A6 (es) Procedimiento para preparar esteres adamantilicos liposolubles de vitamina c.
KR890001582A (ko) 향류머티스제
JO1531B1 (en) New near-compounds
UA16000A1 (uk) Спосіб лікуваhhя гіпотрофії поросят

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060129